Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05995782
PHASE1

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

Sponsor: 1ST Biotherapeutics, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics and pharmacodynamics of oral doses of FB418 in healthy adult subjects and healthy elderly subjects.

Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, SAD and MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral FB418 in Healthy Adult Subjects and Healthy Elderly Subjects

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2023-12-20

Completion Date

2024-12

Last Updated

2024-12-02

Healthy Volunteers

Yes

Interventions

DRUG

FB418

Oral dose

Locations (1)

Seoul National University

Seoul, South Korea